Automatic Pancreatic Ductal Adenocarcinoma Detection in Whole Slide Images Using Deep Convolutional Neural Networks
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: The tested patch-level classification accuracy was 95.33%; whole-slide detection/segmentation results were also reported.
Technology: A deep convolutional network classified and segmented pancreatic ductal adenocarcinoma whole-slide histopathology images.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- A deep convolutional network classified and segmented pancreatic ductal adenocarcinoma whole-slide histopathology images.
- Limitation / still unknown
- Pathologist-confirmed 60 normal and 171 cancer samples with test evaluation; performance does not establish clinical workflow or external generalization.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.665929/full · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.665929/full#s2 · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.665929/full#s3–s4 · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.665929/full#s2–s4 · https://pubmed.ncbi.nlm.nih.gov/34249702/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.